BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 13747508)

  • 1. [Therapeutic experiences with the combination of roentgen rays and a cytostatic agent in model experiments with Jensen sarcoma in rats. III. Morphological studies on the spleen and bone marrow of treated animals].
    SCHERER E; RINGLEB D; SCHOTT H
    Strahlentherapie; 1961 Jun; 115():219-32. PubMed ID: 13747508
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic experiences with the combination of roentgen irradiation and a cytostatic agent in model studies on the Jensen sarcoma of the rat].
    DU MESNIL DE ROCHEMONT R; RINGLEB D; SCHNEIDER H
    Strahlentherapie; 1959; 109():211-25. PubMed ID: 13818262
    [No Abstract]   [Full Text] [Related]  

  • 3. [CONTRIBUTION TO THE MECHANISM OF ACTION OF SOME CYTOSTATICS AND IONIZING RAYS. 1. MORPHOLOGICAL AND FUNCTIONAL STUDIES ON THE BONE MARROW AND SPLEEN OF NORMAL INBRED RATS WITHOUT TRANSPLANTED TUMORS].
    SCHNEIDER R
    Strahlentherapie; 1965 Feb; 126():213-35. PubMed ID: 14271552
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study of bone marrow cellularity in selective testing of the anti-tumor action of cytostatic drugs. Determination of the optimum of selectivity].
    Rosin S
    Stud Cercet Med Interna; 1967; 8(1):89-96. PubMed ID: 6043548
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies on the in vivo cytostatic effect of certain synthetic carbamic acid esters. II. The carcinolytic effect on experimental Jensen sarcoma].
    Teitel A; Demetrescu C; Görk E; Chiriţă C; Gheorghiu P; Mavrodin A
    Acta Biol Med Ger; 1965; 15(3):331-42. PubMed ID: 5888107
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies on the long-range effect of radiogenic products. 3. Effect on P32 uptake of Jensen's sarcoma in vitro by serum of rats following treatment with a cytostatic agent, after burn, and after tumor implantation].
    Rose H; Fischer H
    Radiobiol Radiother (Berl); 1967; 8(5):633-40. PubMed ID: 5605118
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on the mode of action of the cytostatic 1,4-di-mesyloxyethylamino-1,4-dideoxy-m-erythritol (R-74).
    Csányi E; Elekes I
    Neoplasma; 1972; 19(3):189-98. PubMed ID: 5047464
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of cytostatic alkylating agents on deoxyribonucleo protein complex of lymphatic and haemopoetic tissue.
    Matyásová J; Skalka M
    Neoplasma; 1966; 13(4):433-42. PubMed ID: 5921852
    [No Abstract]   [Full Text] [Related]  

  • 9. [Characteristics of the restorative processes in the bone marrow of animals during the administration of cytostatic preparations].
    Gol'dberg DI; Gol'dberg ED; Karpova FV; Dalinger LM; Golubev IV; Antipov IG; Dedova LS; Koifman EK; Kraiushkina NP; Kim EA; Grimberg LG; Novitskiĭ VV; Makarov AS
    Probl Gematol Pereliv Krovi; 1970 Apr; 15(4):45-51. PubMed ID: 5453831
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effect of the newly-developed Czechoslovak cytostatic, Benfluron, on the morphology of the blood and bone marrow in laboratory rats].
    Berger J; Nĕmec J
    Cas Lek Cesk; 1986 Aug; 125(31):969-73. PubMed ID: 3731239
    [No Abstract]   [Full Text] [Related]  

  • 11. Effectiveness of chrysomallin under experimental conditions.
    Silant'ev VV
    Fed Proc Transl Suppl; 1966; 25(1):88-90. PubMed ID: 4158887
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cultivation in vitro of bone marrow and spleen of rabbits irradiated with roentgen rays].
    GUBIN VA
    Arkh Anat Gistol Embriol; 1960 Nov; 39():3-10. PubMed ID: 13709377
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of erythropoietin and bone marrow transfusions on erythropoiesis inhibited by cytostatic agents].
    Künkel HA; Schmaltz AA
    Strahlentherapie; 1970 Nov; 140(5):519-24. PubMed ID: 5497598
    [No Abstract]   [Full Text] [Related]  

  • 14. A MITOMYCIN C-RESISTANT JENSEN RAT SARCOMA: CHEMOTHERAPY STUDIES.
    SUGIURA K; MERKER PC
    Cancer Res; 1963 Sep; 23():SUPPL 1475-82. PubMed ID: 14070402
    [No Abstract]   [Full Text] [Related]  

  • 15. [Stimulation of sarcoma-45 growth resulted from preliminary injection of the tumor tissue treated with Lonin-3].
    Montsevichiute-Eringene
    Vopr Onkol; 1965; 11(10):81-4. PubMed ID: 5872971
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the question of a causative correlation between glycolysis inhibition and cytostatic effect of trenimon].
    Obrecht P; Fusenig NE
    Verh Dtsch Ges Inn Med; 1967; 73():357-61. PubMed ID: 5591775
    [No Abstract]   [Full Text] [Related]  

  • 17. [Apropos of the increase of tumor growth following vaccination with rat sarcoma 45 treated in vitro with lonin-3].
    Moncevichute-Eringhene EV
    Biull Eksp Biol Med; 1965 Jul; 60(7):98-101. PubMed ID: 5880717
    [No Abstract]   [Full Text] [Related]  

  • 18. [Further study of the immunological stimulation of tumor growth in rat vaccination with the tissue of rat sarcoma 45, treated with Lonin-3].
    Montsevichiute-Erigene EV
    Patol Fiziol Eksp Ter; 1966; 10(4):57-62. PubMed ID: 5237744
    [No Abstract]   [Full Text] [Related]  

  • 19. [Morphological picture of the bone marrow from data of trepanobiopsy of the ilium in patients with erythremia during treatment with cytostatic agents].
    Demidova AV; Khandzhian KG
    Probl Gematol Pereliv Krovi; 1970 Dec; 15(12):28-31. PubMed ID: 5499122
    [No Abstract]   [Full Text] [Related]  

  • 20. Amifostine protects bone marrow from benzene-induced hematotoxicity in mice.
    Yu K; Yang KY; Ren XZ; Chen Y; Liu XH
    Int J Toxicol; 2007; 26(4):315-23. PubMed ID: 17661222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.